Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received November 19, 2024 Accepted February 4, 2025

DOI: https://doi.org/10.3350/cmh.2024.1038 [Accepted]

View: 1958 Download: 557 Crossref: 1

Editorial

Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Pengde Lu, Ning Wang

Received March 11, 2025 Accepted March 15, 2025

DOI: https://doi.org/10.3350/cmh.2025.0282 [Accepted]

View: 244 Download: 19

Correspondence

Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received March 12, 2025 Accepted March 15, 2025

DOI: https://doi.org/10.3350/cmh.2025.0287 [Accepted]

View: 299 Download: 22

Editorial

GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen

Received March 18, 2025 Accepted March 21, 2025

DOI: https://doi.org/10.3350/cmh.2025.0315 [Accepted]

View: 216 Download: 17

Correspondence

Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”

Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun

Received March 28, 2025 Accepted April 2, 2025

DOI: https://doi.org/10.3350/cmh.2025.0350 [Accepted]

View: 133 Download: 3

1 |

Viewed By 8228	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7281	MAFLD: How is it different from NAFLD?
Viewed By 5269	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4926	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4512	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 288	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search